Phase I/II study of mocetinostat in combination with gemcitabine for patients with advanced pancreatic cancer and other advanced solid tumors
Crossref DOI link: https://doi.org/10.1007/s00280-017-3494-3
Published Online: 2017-12-13
Published Print: 2018-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chan, Emily
Chiorean, E. Gabriela
O’Dwyer, Peter J.
Gabrail, Nashat Y.
Alcindor, Thierry
Potvin, Diane
Chao, Richard
Hurwitz, Herbert
Funding for this research was provided by:
Mirati Therapeutics Inc.
License valid from 2017-12-13